Significance of ALT/AST ratio for specifying subjects with metabolic syndrome in its silent stage

Hideki Ohgo, Hirokazu Yokoyama, Hiroshi Hirose, Hiroshi Kawabe, Ikuo Saito, Kengo Tomita, Toshifumi Hibi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Aims: Association between metabolic syndrome (MetS) and non-alcoholic fatty liver disease (NAFLD) was verified and significance of liver function tests, especially alanine aminotransferase/aspartate aminotransferase ratio (ALT/AST) to evaluate the statuses of MetS and/or visceral fat accumulation was examined. Materials and Methods: After excluding subjects with liver diseases other than NAFLD, 1643 male and 1764 female Japanese were cross-sectionally examined. The diagnosis of MetS was done by its clinical criteria for Japanese with some modifications. Results: Levels of AST, ALT, gamma glutamyl transpeptidase and ALT/AST were significantly higher in subjects with MS than in those without it. Stepwise regression analyses indicated that AST, ALT, and ALT/AST in male and ALT/AST in female were significantly associated with waist circumference (WC), a marker of visceral fat accumulation. Among these associations, the association between WC and ALT/AST was always significant even when subjects with normal level of ALT of WC were selectively examined. Conclusions: NAFLD can be considered as one of morbid conditions of MetS, i.e. visceral fat accumulation. Among liver function test items, ALT/AST could be a powerful index reflecting their progression even in their pre-diagnosis/silent phases.

Original languageEnglish
Pages (from-to)3-6
Number of pages4
JournalDiabetes and Metabolic Syndrome: Clinical Research and Reviews
Volume3
Issue number1
DOIs
Publication statusPublished - 2009 Jan

Fingerprint

Aspartate Aminotransferases
Alanine Transaminase
Intra-Abdominal Fat
Waist Circumference
Liver Function Tests
gamma-Glutamyltransferase
Liver Diseases
Regression Analysis
Non-alcoholic Fatty Liver Disease

Keywords

  • ALT/AST
  • Metabolic syndrome
  • Non-alcoholic fatty liver disease
  • Visceral fat accumulation
  • Waist circumference

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Significance of ALT/AST ratio for specifying subjects with metabolic syndrome in its silent stage. / Ohgo, Hideki; Yokoyama, Hirokazu; Hirose, Hiroshi; Kawabe, Hiroshi; Saito, Ikuo; Tomita, Kengo; Hibi, Toshifumi.

In: Diabetes and Metabolic Syndrome: Clinical Research and Reviews, Vol. 3, No. 1, 01.2009, p. 3-6.

Research output: Contribution to journalArticle

@article{47fdba6930d1411ab2f0630e5ab9497f,
title = "Significance of ALT/AST ratio for specifying subjects with metabolic syndrome in its silent stage",
abstract = "Aims: Association between metabolic syndrome (MetS) and non-alcoholic fatty liver disease (NAFLD) was verified and significance of liver function tests, especially alanine aminotransferase/aspartate aminotransferase ratio (ALT/AST) to evaluate the statuses of MetS and/or visceral fat accumulation was examined. Materials and Methods: After excluding subjects with liver diseases other than NAFLD, 1643 male and 1764 female Japanese were cross-sectionally examined. The diagnosis of MetS was done by its clinical criteria for Japanese with some modifications. Results: Levels of AST, ALT, gamma glutamyl transpeptidase and ALT/AST were significantly higher in subjects with MS than in those without it. Stepwise regression analyses indicated that AST, ALT, and ALT/AST in male and ALT/AST in female were significantly associated with waist circumference (WC), a marker of visceral fat accumulation. Among these associations, the association between WC and ALT/AST was always significant even when subjects with normal level of ALT of WC were selectively examined. Conclusions: NAFLD can be considered as one of morbid conditions of MetS, i.e. visceral fat accumulation. Among liver function test items, ALT/AST could be a powerful index reflecting their progression even in their pre-diagnosis/silent phases.",
keywords = "ALT/AST, Metabolic syndrome, Non-alcoholic fatty liver disease, Visceral fat accumulation, Waist circumference",
author = "Hideki Ohgo and Hirokazu Yokoyama and Hiroshi Hirose and Hiroshi Kawabe and Ikuo Saito and Kengo Tomita and Toshifumi Hibi",
year = "2009",
month = "1",
doi = "10.1016/j.dsx.2008.10.001",
language = "English",
volume = "3",
pages = "3--6",
journal = "Diabetes and Metabolic Syndrome: Clinical Research and Reviews",
issn = "1871-4021",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - Significance of ALT/AST ratio for specifying subjects with metabolic syndrome in its silent stage

AU - Ohgo, Hideki

AU - Yokoyama, Hirokazu

AU - Hirose, Hiroshi

AU - Kawabe, Hiroshi

AU - Saito, Ikuo

AU - Tomita, Kengo

AU - Hibi, Toshifumi

PY - 2009/1

Y1 - 2009/1

N2 - Aims: Association between metabolic syndrome (MetS) and non-alcoholic fatty liver disease (NAFLD) was verified and significance of liver function tests, especially alanine aminotransferase/aspartate aminotransferase ratio (ALT/AST) to evaluate the statuses of MetS and/or visceral fat accumulation was examined. Materials and Methods: After excluding subjects with liver diseases other than NAFLD, 1643 male and 1764 female Japanese were cross-sectionally examined. The diagnosis of MetS was done by its clinical criteria for Japanese with some modifications. Results: Levels of AST, ALT, gamma glutamyl transpeptidase and ALT/AST were significantly higher in subjects with MS than in those without it. Stepwise regression analyses indicated that AST, ALT, and ALT/AST in male and ALT/AST in female were significantly associated with waist circumference (WC), a marker of visceral fat accumulation. Among these associations, the association between WC and ALT/AST was always significant even when subjects with normal level of ALT of WC were selectively examined. Conclusions: NAFLD can be considered as one of morbid conditions of MetS, i.e. visceral fat accumulation. Among liver function test items, ALT/AST could be a powerful index reflecting their progression even in their pre-diagnosis/silent phases.

AB - Aims: Association between metabolic syndrome (MetS) and non-alcoholic fatty liver disease (NAFLD) was verified and significance of liver function tests, especially alanine aminotransferase/aspartate aminotransferase ratio (ALT/AST) to evaluate the statuses of MetS and/or visceral fat accumulation was examined. Materials and Methods: After excluding subjects with liver diseases other than NAFLD, 1643 male and 1764 female Japanese were cross-sectionally examined. The diagnosis of MetS was done by its clinical criteria for Japanese with some modifications. Results: Levels of AST, ALT, gamma glutamyl transpeptidase and ALT/AST were significantly higher in subjects with MS than in those without it. Stepwise regression analyses indicated that AST, ALT, and ALT/AST in male and ALT/AST in female were significantly associated with waist circumference (WC), a marker of visceral fat accumulation. Among these associations, the association between WC and ALT/AST was always significant even when subjects with normal level of ALT of WC were selectively examined. Conclusions: NAFLD can be considered as one of morbid conditions of MetS, i.e. visceral fat accumulation. Among liver function test items, ALT/AST could be a powerful index reflecting their progression even in their pre-diagnosis/silent phases.

KW - ALT/AST

KW - Metabolic syndrome

KW - Non-alcoholic fatty liver disease

KW - Visceral fat accumulation

KW - Waist circumference

UR - http://www.scopus.com/inward/record.url?scp=62749179603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62749179603&partnerID=8YFLogxK

U2 - 10.1016/j.dsx.2008.10.001

DO - 10.1016/j.dsx.2008.10.001

M3 - Article

VL - 3

SP - 3

EP - 6

JO - Diabetes and Metabolic Syndrome: Clinical Research and Reviews

JF - Diabetes and Metabolic Syndrome: Clinical Research and Reviews

SN - 1871-4021

IS - 1

ER -